Skip to content

Enhanced Diagnostics for Early Detection of Atrial Fibrillation - Prospective Validation

Enhanced Diagnostics for Early Detection of Atrial Fibrillation - Prospective Validation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02949180
Acronym
DETECTAF-pro
Enrollment
672
Registered
2016-10-31
Start date
2016-10-31
Completion date
2017-11-30
Last updated
2017-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmia Atrial, Atrium; Fibrillation

Keywords

Atrial fibrillation, Rhythm monitoring, Cardiovascular App, m-health

Brief summary

Prospective, blinded, multicenter international trial to test the Preventicus Heartbeats App in a prospective cohort.

Detailed description

Introduction This algorithm was validated earlier in a clinical trial with retrospective Data. The results were published accordingly.The algorithm is implemented in the commercial App Preventicus Heartbeats. DETECT AF is designed as prospective follow up trial. Study design Prospective, blinded, multicenter international trial. Methods The subjects will be asked to position a smartphone on their index finger to allow their pulse curve to be recorded for five minutes. At the same time, an ecg will be recorded using an digital mobile ecg recorder as a reference. Data will be collected on person-related information, comorbidities and medication (estimated overall duration/patient \<20 min). No follow-up is planned. Analogous to predecessor studies, the pulse wave curve data are coded with the patient's identification number (ID) and externally analyzed at Preventicus; based on the results, the subjects will be assigned to SR/AF groups. After evaluation of all files, the grouped results will be aggregated, unblinded and evaluated under monitoring. Primary target parameters are the app's sensitivity and specificity in correctly detecting atrial fibrillation compared to an automatically interpreted ECG. Secondary target parameters include the proportion of non-evaluable recordings in the overall study.

Interventions

DEVICEFive minutes puls wave recording

iPhone will be positioned on the index finger for five minutes to record a pulse wave

Sponsors

University Hospital Greifswald
CollaboratorOTHER
University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Subjects of legal age, * patients with either sinus rhythm (Group SR) or atrial fibrillation (Group AF) * informed consent

Exclusion criteria

* Legally incompetent persons

Design outcomes

Primary

MeasureTime frameDescription
Correct detection of atrial fibrillation5 minutesiPhone will be positioned on the index finger for five minutes to record a pulse wave; Algorithm should correctly differentiate between AF patients and SR patients

Countries

Germany, Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026